Inhibrx Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | BMY | AMGN | GILD | VRTX |
| Company | Inhibrx Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 34.10 | 43.75 | 308.00 | 65.44 | 413.33 |
| High | 34.48 | 43.75 | 308.00 | 65.44 | 425.65 |
| Low | 34.10 | 43.75 | 308.00 | 65.44 | 412.12 |
| Last | 34.44 | 43.75 | 308.00 | 65.44 | 418.82 |
| Change | +0.05 | +0.08 | +0.69 | +0.52 | +8.58 |
| % Change | +0.15% | +0.18% | +0.22% | +0.80% | +2.09% |
| Volume | 371,300 | 4,378 | 762 | 10,911 | 1,651,600 |
| 20-Day Average Volume | 314,855 | 13,817,764 | 2,761,248 | 7,160,420 | 1,133,780 |
| Previous Close | 34.39 | 43.67 | 307.31 | 64.92 | 410.24 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 34.36 | 46.13 | 279.22 | 66.14 | 399.69 |
| 20-Day Raw Stochastic | 42.18% | 6.70% | 76.42% | 25.87% | 80.28% |
| 20-Day Relative Strength | 46.93% | 29.45% | 66.21% | 35.95% | 59.98% |
| Weighted Alpha | +41.43 | -36.68 | +32.74 | -20.17 | +21.35 |
| Today's Opinion | 8% Buy | 100% Sell | 56% Buy | 100% Sell | 56% Buy |
| Previous Opinion | Hold | 100% Sell | 56% Buy | 100% Sell | 32% Buy |
| Last Month's Opinion | 40% Buy | 48% Sell | 40% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.41% since 05/01/24 | +0.11% since 05/02/24 | +10.64% since 05/02/24 | +0.17% since 05/02/24 | +4.15% since 05/01/24 |
| Low | 33.87 on 05/03/24 | 43.56 on 05/08/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 |
| High | 34.48 on 05/08/24 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -0.75% since 04/08/24 | -15.21% since 04/09/24 | +13.92% since 04/09/24 | -6.43% since 04/09/24 | +3.61% since 04/08/24 |
| Low | 33.72 on 04/26/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 35.42 on 04/11/24 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -7.57% since 02/08/24 | -12.17% since 02/09/24 | +5.80% since 02/09/24 | -11.17% since 02/09/24 | -1.00% since 02/08/24 |
| Low | 33.72 on 04/26/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 39.79 on 02/27/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +80.50% since 11/08/23 | -13.21% since 11/09/23 | +16.64% since 11/09/23 | -12.72% since 11/09/23 | +11.10% since 11/08/23 |
| Low | 16.83 on 11/10/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 39.79 on 02/27/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,800,454 | 88,523,448 | 164,851,840 | 80,830,400 | 108,247,808 |
| Shares Outstanding, K | 52,278 | 2,027,100 | 536,435 | 1,245,077 | 258,459 |
| Annual Sales | 1,800,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -241,360,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,630,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -93,600,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 2.87 | 0.45 | 0.60 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.73 on 02/28/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.94 | 16.12 | 16.24 | 27.24 |